Skip to content
Research/Peptide Blends Stacks/Thymosin Alpha-1 + KPV + LL-37

Thymosin Alpha-1 + KPV + LL-37

Immune Triad. Comprehensive immune support stack combining T-cell activation (TA-1), anti-inflammatory (KPV), and antimicrobial/immune (LL-37). Broad immune support.

Intelligence Profile

Science

Mechanism of Action

Limited evidence available for this combination therapy.

This compound combines three distinct immunomodulatory peptides: Thymosin Alpha-1, KPV, and LL-37. However, no specific research evidence was retrieved examining how these three agents work together as a combination therapy.

Individual peptide mechanisms (when studied separately):

While we lack evidence for this specific combination, the individual components have been studied:

  • Thymosin Alpha-1 has been investigated as an immune system modulator that may influence T-cell function and cytokine production
  • KPV is a tripeptide derived from α-melanocyte-stimulating hormone that has been studied for potential anti-inflammatory properties
  • LL-37 is an antimicrobial peptide naturally found in humans that has been researched for its role in innate immunity

Evidence limitations:

The absence of retrieved studies means we cannot determine:

  • Whether these peptides have synergistic, additive, or potentially conflicting effects when combined
  • Optimal dosing ratios for the combination
  • Pharmacokinetic interactions between the components
  • Clinical efficacy or safety profile of the triple combination

Disclaimer: This information is for educational purposes only and should not be considered medical advice. Consult with a qualified healthcare provider before considering any peptide therapy.

More research is needed to understand the molecular mechanisms and clinical effects of this specific three-peptide combination.